What es
AELMHU?
We are a non-profit association made up of pharmaceutical companies, specialised in rare diseases, that are committed to discovering, researching, developing and commercialising innovative therapies that improve the lives of patients and their families.
AccessReport
AELMHU prepares, on a quarterly and annual basis,
reports on access to orphan drugs in Spain.
NEWS
NEWS
With the aim of highlighting the benefits of orphan therapies, not only for patients and their families, but also in economic terms for the health system, the document "Differential aspects of orphan therapies" has been presented in ... Read more
Judging of the Jury of the
AELMHU Awards 2024
AELMHU and the Consejo General de Colegios Farmacéuticos (General Council of Pharmaceutical Associations)
AELMHU renews its Board of Directors
Report on clinical trials
in Spain
INTERVIEWS
INTERVIEWS
Interview with Dr. Montserrat Morales, Coordinator of the Adult Unit for Rare Diseases and Inborn Errors of Metabolism at the Hospital Universitario 12 de Octubre in Madrid.
Interview with Dr. Begoña Polo, medical expert in Familial Intrahepatic Cholestasis.
ASSOCIATED COMPANIES
RESEARCH AND COMMITMENT to rare diseases
MEMBERS
Do you want to be part of AELMHU?
